Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

This study has been terminated.
(Closed due to insufficient recruitment.)
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00234442
First received: October 5, 2005
Last updated: June 29, 2009
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: February 2006
  Estimated Primary Completion Date: No date given